Charles King, Cape Peninsula University of Technology
Consensual same-sex conduct is a crime in 38 African countries. The media in those countries are very much in cahoots with their rulers. But they’re getting their comeuppance from Twitter.
Academics have sent an open letter to the World Health Organisation calling for the Olympics to be postponed or moved because of the Zika threat. They’re overreacting.
The messages that adolescents receive from sexuality education classes are frequently negative. It’s time for the curriculum to become more empowering for learners and teachers.
New guidelines from the World Health Organization mean more people are eligible for antiretrorviral therapy. It’s critical to find ways for people to start treatment without multiple clinic visits.
In South Africa, female sex workers go for HIV tests, receive counselling and use condoms – but don’t access antiretroviral treatments. More options are now available and can change this.
In countries such as South Africa with a high burden of TB and HIV, vitamin D could be an extremely effective and cheap weapon to include in the arsenal against TB and HIV.
Antiretroviral treatment has been free at Nigeria’s health facilities. But the other costs involved for those living with HIV, such as transport and food, have been problematic.
Thanks to treatment advances, people with HIV can and do live long and full lives. And that has led to a challenge that doctors and patients may not have imagined 35 years ago: the aging HIV patient.
With nearly one-fifth of the globe’s HIV positive population, South Africa has the largest anti-retroviral program in the world. But HIV prevention still presents a big challenge for the country.
Lynn Morris, University of the Witwatersrand; Nono Mkhize, National Institute for Communicable Diseases; Penny Moore, University of the Witwatersrand, and Zanele Ditse, National Institute for Communicable Diseases
Two major clinical trials will be conducted in South Africa in 2016 to test ways of preventing new HIV infections.
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand